2
项与 Natural Killer Cells(Instituto de Investigación Hospital Universitario La Paz) 相关的临床试验Multicenter, Open-label, Phase I/II Clinical Trial of Infusion of Activated NK Cells for the Treatment of Children, Adolescents and Young Adults With Sarcomas
This is an exploratory therapeutic study (according to the terminology of the "ICH Harmonised Tripartite Guideline Topic E8. General Considerations for Clinical Trials". EMEA, March 1998. CPMP/ICH/291/95), open-label, non-randomized, multicenter study. It is considered phase I/II since the safety and efficacy of the infusion of allogeneic haploidentical NK cells in combination with chemotherapy and/or radiotherapy in the treatment of pediatric, adolescent and young adult patients with refractory sarcoma will be sought.
Phase I / II Study on Infusion of Alloreactive or Stimulated Natural Killer Cells With IL-15 ex Vivo After Haploidentical Transplantation of Hematopoietic Progenitors in Pediatric Patients With Hematological Neoplasms
Phase I / II study on infusion of alloreactive or stimulated Natural Killer cells with IL-15 ex vivo after haploidentical transplantation of hematopoietic progenitors in pediatric patients with hematologic malignancies (PHINK
100 项与 Natural Killer Cells(Instituto de Investigación Hospital Universitario La Paz) 相关的临床结果
100 项与 Natural Killer Cells(Instituto de Investigación Hospital Universitario La Paz) 相关的转化医学
100 项与 Natural Killer Cells(Instituto de Investigación Hospital Universitario La Paz) 相关的专利(医药)
100 项与 Natural Killer Cells(Instituto de Investigación Hospital Universitario La Paz) 相关的药物交易